Following a report of the analysis of data from the SEER registries of the NCI, showing that the incidence of breast cancer fell by 6.7 percent in 2003 in the US, and the suggestion that the data might be linked to the decrease in the use of postmenopausal hormones, the IMS advises caution in linking these two trends and recommends that hormone therapy be prescribed whenever indicated.
The U.S. Food and Drug Administration (FDA) proposed recommendations to Congress for reauthorizing the Medical Device User Fee and Modernization Act (MDUFMA II), which, if adopted, would help to ensure that safe and effective medical devices get to patients in a timely manner.
As US Congress prepares to vote on the most significant prescription drug safety legislation in 45 years, a new Consumer Reports poll finds that the American public strongly backs a host of key safety reforms.
AARP will be sending the following letter from CEO Bill Novelli to every member of the U.S. Senate alerting them that the association will be recording the upcoming Senate vote on a bill to allow Medicare to negotiate for lower prescription drug prices.
More than 22,300 NHS posts have been lost in the last 18 months because of the financial crisis hitting the health service, according to a new report from the Royal College of Nursing (RCN).
Today, the long-awaited federally funded evaluation of abstinence-only-until-marriage programs was released showing that the programs had no impact on teen behavior.
Five leading experts will be featured in a special half-day symposium on state-of-the-art obesity management in women at the 15th Annual Congress on Women?s Health, June 2-5, 2007, Hilton Head, SC at the Hilton Head Marriott Beach & Golf Resort.
A first-of-its-kind report looking at the prevalence and cost of type 2 diabetes complications shows that an estimated three out of five people (57.9 percent) with type 2 diabetes have at least one of the other serious health problems commonly associated with the disease, and that these health problems are taking a heavy financial toll on the United States.
As part of the Food and Drug Administration’s (FDA) on-going initiative to ensure that all marketed U.S. drugs have required marketing approval, the agency announced that companies must stop manufacturing and distributing unapproved suppository drug products containing trimethobenzamide hydrochloride.
Sheep gene research at the University of Adelaide’s Roseworthy Campus aimed at helping maximise wool production for Australian producers, has shed light on a human genetic hair and skin disorder.